Mr K V Venugopalan, president, Waters India
Waters creates business advantages for laboratory-dependent organizations by delivering practical and sustainable scientific innovation to enable significant advancement in healthcare delivery, environmental management, food safety, and water quality. For the FY 2013-14, the company recorded revenue of Rs 564 crore, which is an increase by Rs 60 crore compared to FY 2012-13.
Waters division products are used by pharmaceutical, life science, biochemical, industrial, academic and government organizations working in research and development, quality assurance and other laboratory applications.
The company's exports account for nearly two-thirds of sales while the company's largest single market is the pharmaceutical industry. The year 2014 marks Waters Corporation's 56th year of analytical instrument industry innovation.
While the company offers a broad array of technologies, it still maintains platform products in four key areas: instruments, chemistries, software, and services.
Its best known brands are ACQUITY UPLC Systems, ACQUITY UPLC BEH, XBridge, Sunfire, Symmetry, Atlantis, XTerra and Cortecs and columns for analytical - to preparative-scale chromatography and eLab Notebook Software.
The biopharma business for Waters India is consistently growing. In India the LC instrumentation business contributed to the major chunk of its business, while mass spectrometry uptake also witnessed a jump in the sales.